MarginsXMarginsX
Home › Markets › Health Care › AIDX

20/20 Biolabs Inc. (AIDX)

AIDX trades on Nasdaq in Health Care, Precision Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.1850
-9.45% on the day
Market cap
$2.5M
Nano cap
Revenue · 2025
$2.0M
+16.7% on 2024
Net income · 2025
-$3.7M
-182.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1139685/000121390026037667/0001213900-26-037667-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerAIDX on Nasdaq
SectorHealth Care
IndustryPrecision Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001139685
SEC industry codeServices-Testing Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.0M
Net income-$3.7M
Operating income-$3.3M
Net margin-182.8%
Operating margin-162.9%
Revenue growth+16.7%
Cash$1.0M
Total assets$4.1M
P/E (computed)Net income was not positive
P/S (computed)1.2×

Warning signs

Cash runway
18.7 months
$4.5M cash at June 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-14
Cash and burn$4.5M cash; operating cash flow -$729K a quarter.Report 2026-06-30
Shares outstanding12,770,303 (2026-08-14).Cover page 2026-08-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-09-10
AuditorDBBMCKENNON, San Diego, California, United StatesPCAOB Form AP 2026-04-01
Late filings, 12 months1 NT noticeNT 10-Q 2026-05-15
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$731K-$1.5M-$605K$4.5MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
$353K-$2.2M-$1.3M$4.2M$307KNeeds four quarters10-Q 2026-05-20
Q2 2025
2025-06-30
$535K-$841K-$534K$1.0MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
$554K-$765K-$488K$1.6MNo debt tagsNeeds four quarters10-Q 2026-05-20

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B32026-08-17
Latest annual report
ANNUAL REPORT
10-K2026-03-31
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-16
Latest current report
CURRENT REPORT
8-K2026-11-16
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-10-21

Source: SEC EDGAR submissions feed, 169 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week0.0%
1 month-42.9%
3 months-61.5%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-99.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Precision Instruments

TickerCompanyPriceDayMarket cap
NEONeoGenomics Inc.$15.41-3.81%$2.0B
ULSUL Solutions Inc.$78.13-2.77%$15.8B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier